El Coronado Holdings, LLC

CIK 1319763 · last filed 2014-07-02

El Coronado Holdings, LLC is a corporate insider who has filed 89 SEC Form 4 insider transactions across 2 companies since 2007. Across all open-market trades the lifetime net is +$47.8M, making them a net buyer over the disclosed history. The firm reports its address in Dallas, TX. 198 SEC filings were submitted jointly with JOSIAH T AUSTIN.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

2

Total Filings

89

Lifetime Open-Market Net

$47.83M

Filer Profile

Reported Address

4673 CHRISTOPHER PLACE
DALLAS, TX 75204

Phone

(214) 520-1684

State of Incorporation

Related Filers

JOSIAH T AUSTIN — 198 joint filings, latest 2014-11-04

NOVOGEN LTD — 57 joint filings, latest 2013-11-06

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Chelsea Therapeutics International, Ltd. (CHTP) Delisted	10%+ Owner	6,871,981	—	—	$22.59M	54	2012-12-19
NOVOGEN LTD (NVGN) Delisted	10%+ Owner	4,064,611	—	—	$25.24M	28	2008-07-31

Recent Filings

89 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2014-07-02	—	Buy (P)	—	$0
2014-02-13	—	Mixed	+10,505,112	$5.25M
2013-09-16	—	Buy (P)	+1,049,612	$524.8K
2013-06-14	—	Buy (P)	+1,120,000	$560.0K
2013-01-07	—	Buy (P)	—	$0
2012-12-19	Chelsea Therapeutics International, Ltd. (CHTP) Delisted	Sell (S)	−1,377,114	-$1.28M	EDGAR
2012-12-14	Chelsea Therapeutics International, Ltd. (CHTP) Delisted	Sell (S)	−798,828	-$838.8K	EDGAR
2011-10-19	Chelsea Therapeutics International, Ltd. (CHTP) Delisted	Buy (P)	+4,200	$18.4K	EDGAR
2011-02-15	Chelsea Therapeutics International, Ltd. (CHTP) Delisted	Exer (X)	+240,000	$1.01M	EDGAR
2010-06-08	Chelsea Therapeutics International, Ltd. (CHTP) Delisted	Buy (P)	+20,000	$63.8K	EDGAR

Showing 1–10 of 89

Page 1 of 9 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.